Development and metrological characterization of quantitative X-ray diffraction phase analysis for the mixtures of clopidogrel bisulphate polymorphs

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 4, 2008, Pages 676-682

  Uvarov, Vladimir ^a   Popov, Inna ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Clopidogrel; Drug polymorphism; Metrological characterization; Quantitative phase analysis; Whole powder pattern decomposition method; X ray diffraction

Indexed keywords

CLOPIDOGREL;

ACCURACY; ANALYTICAL ERROR; ARTICLE; COMPUTER PROGRAM; DECOMPOSITION; DRUG MIXTURE; DRUG STRUCTURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STATISTICAL ANALYSIS; WHOLE POWDER PATTERN DECOMPOSITION METHOD; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

TICLOPIDINE; X-RAY DIFFRACTION;

EID: 39149089987     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.11.026     Document Type: Article

References (29)

1. Knapman K. Mod. Drug Disc. 3 (2000) 53-57
2. Sheth A.R., and Grant D.J.W. Kona 23 (2005) 36-48
3. Lyseng-Williamson K.A., and Plosker G.L. Pharmacoeconomics 24 7 (2006) 709-726
4. A. Bousquet, B. Castro, S. Germain, Polymorphic Form of Clopidogrel Hydrogen Sulphate, US Patent no. 6504030 (2003).
5. M. Vickers, Online report, http://img.chem.ucl.ac.uk/www/reports/clopi/clopi.htm (2003).
6. Koradia V., Chawla G., and Bansal A. Acta Pharm. 54 (2004) 193-204
7. Stephenson G.A., Forbes R.A., and Reutzel-Edens S.M. Adv. Drug Deliv. Rev. 48 (2001) 67-90
8. Newnan A.W., and Byrn S.R. Drug Discovery Today 8 1 (2003) 898-905
9. Suryanarayanan R., and Herman C.S. Pharm. Res. 8 3 (1991) 393-399
10. Dash A.K., Khin-Khin A., and Suryanarayanan R. J. Pharm. Sci. 91 4 (2002) 983-990
11. Cao W., Bates S., Peck G.E., Wildfong P.L.D., Qiu Z., and Morris K.R. J. Pharm. Biomed. Anal. 30 (2002) 1111-1119
12. Roberts S.N.C., Williams A.C., Grimsey I.M., and Booth S.W. J. Pharm. Biomed. Anal. 28 (2002) 1149-1159
13. Ried J.W., and Hendry J.A. J. Appl. Cryst. 39 (2006) 536-543
14. Yamamura S., and Momose Y. Int. J. Pharm. 212 (2001) 203-212
15. D. Clenet, G. Gasrcia, Fifth International Workshop on Physical Characterization of Pharmaceutical Solids, Ettlingen, Germany (2004) Poster presentation.
16. Toraya H., and Tsusaka S.J. Appl. Cryst. 19 (1995) 392-399
17. Taylor J.C., and Rui Z. Powder Diffr. 7 (1992) 152-161
18. Giannini C., Guagliardi A., and Millini R. J. Appl. Cryst. 35 (2002) 481-490
19. Kraus W., and Nolze G. J. Appl. Cryst. 29 (1996) 301-303
20. L. Luterotti (2006) http://www.ing.unitn.it/∼maud/.
21. Taylor J.C. Powder Diffract. 6 (1991) 2-9
22. Alexander A.L., and Klug H.P. Anal. Chem. 20 (1948) 886-889
23. Le Bail A.H., Duroy J.L., and Fourquet. Mat. Res. Bull. 23 (1988) 447-452
24. P. Tobias, C. Croarkin (Eds.), NIST/SEMATECH Engineering Statistics Internet Handbook, National Institute of Standards and Technology, U.S. Dept. of Commerce, Washington, DC, http://www.itl.nist.gov/div898/handbook/ (2006).
25. Wildfong P.L.D., Morley N.A., Moore M.D., and Morris K.R. J. Pharm. Biomed. Anal. 39 1-2 (2005) 1-7
26. Agatonovic-Kustrin S., Rades T., Wu V., Saville D., and Tucker I.G. J. Pharm. Biomed. Anal. 25 5-6 (2001) 741-750
27. Bugay D.E., Newman A.W., and Findlay W.P. J. Pharm. Biomed. Anal. 15 (1996) 49-61
28. Hill R.J., and Fischer R.X. J. Appl. Cryst. 23 (1990) 462-468
29. Uvarov V., and Popov I. Mat. Charact. 58 10 (2007) 883-891